American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care 42, S13–S28 (2019).
Shamseddeen, H., Getty, J. Z., Hamdallah, I. N. & Ali, M. R. Epidemiology and economic impact of obesity and type 2 diabetes. Surg. Clin. North. Am. 91, 1163–1172 (2011).
Saeedi, P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 157, 107843 (2019).
DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Prim. 1, 15019 (2015).
Huang, E. S. Management of diabetes mellitus in older people with comorbidities. BMJ 353, i2200 (2016).
PubMed PubMed Central Article Google Scholar
Yang, W. et al. Estimating costs of diabetes complications in people <65 years in the U.S. using panel data. J. Diabetes Complicat. 34, 107735 (2020).
Giri, B. et al. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity. Biomed. Pharmacother. 107, 306–328 (2018).
CAS PubMed Article Google Scholar
Paul, S., Ali, A. & Katare, R. Molecular complexities underlying the vascular complications of diabetes mellitus — a comprehensive review. J. Diabetes Complicat. 34, 107613 (2020).
Gomez, C. S., Kanagarajah, P. & Gousse, A. E. Bladder dysfunction in patients with diabetes. Curr. Urol. Rep. 12, 419–426 (2011).
Gandhi, J., Dagur, G., Warren, K., Smith, N. L. & Khan, S. A. Genitourinary complications of diabetes mellitus: an overview of pathogenesis, evaluation, and management. Curr. Diabetes Rev. 13, 498–518 (2017).
Brown, J. S. et al. Urologic complications of diabetes. Diabetes Care 28, 177–185 (2005).
Arrellano-Valdez, F., Urrutia-Osorio, M., Arroyo, C. & Soto-Vega, E. A comprehensive review of urologic complications in patients with diabetes. SpringerPlus 3, 549 (2014).
PubMed PubMed Central Article Google Scholar
Nirmal, J. et al. Functional and molecular characterization of hyposensitive underactive bladder tissue and urine in streptozotocin-induced diabetic rat. PLoS One 9, e102644 (2014).
PubMed PubMed Central Article CAS Google Scholar
Palleschi, G. et al. Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation. World J. Urol. 32, 1021–1025 (2014).
Fayyad, A. M., Hill, S. R. & Jones, G. Prevalence and risk factors for bothersome lower urinary tract symptoms in women with diabetes mellitus from hospital-based diabetes clinic. Int. Urogynecol. J. Pelvic Floor. Dysfunct. 20, 1339–1344 (2009).
Qaseem, A. et al. Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians. Ann. Intern. Med. 168, 569–576 (2018).
Wang, R., Lefevre, R., Hacker, M. R. & Golen, T. H. Diabetes, glycemic control, and urinary incontinence in women. Female Pelvic Med. Reconstr. Surg. 21, 293–297 (2015).
PubMed PubMed Central Article Google Scholar
Liu, N. et al. Relationship between blood glucose and hemoglobin A1c Levels and urinary incontinence in women. Int. J. Gen. Med. 14, 4105–4116 (2021).
PubMed PubMed Central Article Google Scholar
Gulur, D. M., Mevcha, A. M. & Drake, M. J. Nocturia as a manifestation of systemic disease. BJU Int. 107, 702–713 (2011).
Yoshimura, N., Chancellor, M. B., Andersson, K. E. & Christ, G. J. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int. 95, 733–738 (2005).
Fedele, D. Therapy insight: sexual and bladder dysfunction associated with diabetes mellitus. Nat. Clin. Pract. Urol. 2, 282–290 (2005). quiz 309.
Fowler, C. J., Griffiths, D. & de Groat, W. C. The neural control of micturition. Nat. Rev. Neurosci. 9, 453–466 (2008).
CAS PubMed PubMed Central Article Google Scholar
Lightner, D. J., Gomelsky, A., Souter, L. & Vasavada, S. P. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. J. Urol. 202, 558–563 (2019).
Lee, W. C., Wu, C. C., Wu, H. P. & Tai, T. Y. Lower urinary tract symptoms and uroflowmetry in women with type 2 diabetes mellitus with and without bladder dysfunction. Urology 69, 685–690 (2007).
Frimodt-Moller, C. Diabetic cystopathy. A review of the urodynamic and clinical features of neurogenic bladder dysfunction in diabetes mellitus. Dan. Med. Bull. 25, 49–60 (1978).
Kaplan, S. A., Te, A. E. & Blaivas, J. G. Urodynamic findings in patients with diabetic cystopathy. J. Urol. 153, 342–344 (1995).
CAS PubMed Article Google Scholar
Harding, C. K. et al. EAU guidelines on management of non-neurogenic female lower urinary tract symptoms (LUTS). (EAU, 2021).
Abraham, N. & Goldman, H. B. An update on the pharmacotherapy for lower urinary tract dysfunction. Expert. Opin. Pharmacother. 16, 79–93 (2015).
CAS PubMed Article Google Scholar
Kuo, Y.-C. & Kuo, H.-C. Botulinum toxin injection for lower urinary tract dysfunction. Int. J. Urol. 20, 40–55 (2012).
PubMed Article CAS Google Scholar
Bartley, J., Gilleran, J. & Peters, K. Neuromodulation for overactive bladder. Nat. Rev. Urol. 10, 513–521 (2013).
CAS PubMed Article Google Scholar
Chancellor, M. B. & Kaufman, J. Case for pharmacotherapy development for underactive bladder. Urology 72, 966–967 (2008).
Osman, N. I. & Chapple, C. R. Are there pharmacotherapeutic options for underactive bladder? Eur. Urol. Focus. 4, 6–7 (2018).
Barendrecht, M. M., Oelke, M., Laguna, M. P. & Michel, M. C. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int. 99, 749–752 (2007).
CAS PubMed Article Google Scholar
Yuan, Z., Tang, Z., He, C. & Tang, W. Diabetic cystopathy: a review. J. Diabetes 7, 442–447 (2015).
Andersson, K. E. Oxidative stress and its possible relation to lower urinary tract functional pathology. BJU Int. 121, 527–533 (2018).
Pizzino, G. et al. Oxidative stress: harms and benefits for human health. Oxid. Med. Cell. Longev. 2017, 8416763 (2017).
PubMed PubMed Central Google Scholar
Lushchak, V. I. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem. Biol. Interact. 224, 164–175 (2014).
CAS PubMed Article Google Scholar
Sies, H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 4, 180–183 (2015).
CAS PubMed PubMed Central Article Google Scholar
Zuo, L., Zhou, T., Pannell, B. K., Ziegler, A. C. & Best, T. M. Biological and physiological role of reactive oxygen species-the good, the bad and the ugly. Acta Physiol. 214, 329–348 (2015).
Zhang, L. et al. Biochemical basis and metabolic interplay of redox regulation. Redox Biol. 26, 101284 (2019).
CAS PubMed PubMed Central Article Google Scholar
Brand, M. D. The sites and topology of mitochondrial superoxide production. Exp. Gerontol. 45, 466–472 (2010).
CAS PubMed PubMed Central Article Google Scholar
Roberge, S. et al. TNF-α-mediated caspase-8 activation induces ROS production and TRPM2 activation in adult ventricular myocytes. Cardiovasc. Res. 103, 90–99 (2014).
CAS PubMed Article Google Scholar
Clauzure, M. et al. Disruption of interleukin-1β autocrine signaling rescues complex I activity and improves ROS levels in immortalized epithelial cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function. PLoS One 9, e99257 (2014).
PubMed PubMed Central Article CAS Google Scholar
Sundaresan, M., Yu, Z. X., Ferrans, V. J., Irani, K. & Finkel, T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296–299 (1995).
留言 (0)